[1]
“Impact on diabetes control and patient-reported outcomes of a newer implantable continuous glucose monitoring system (Eversense® CGM System): a single-centre retro- and prospective observational study”, Swiss Med Wkly, vol. 154, no. 3, p. 3366, Mar. 2024, doi: 10.57187/s.3366.